Kevin Crowley

Kevin Crowley has extensive experience in the investment and board roles. Kevin has worked as a Senior Managing Director of Investments at Connecticut Innovations since 2006. In this role, they have led investments in various companies such as Enko, Veradermics, Torigen Pharmaceuticals, Rapid Oxygen Company, Affinimark Technologies, and Cara Therapeutics.

Additionally, Kevin has served as a Board Observer for several companies, including Enko, VeraDermics Inc., BioWave Corporation, Trebel Music, and Wellinks. These companies operate in various industries, such as agriculture, dermatology, pain management technology, music, and healthcare.

Furthermore, Kevin has held board positions in Torigen, Inc., CaroGen Corporation, Uconn Innovation Fund, and Intelligent Clearing Network (ICN). These roles have allowed him to contribute to the development of innovative vaccine immunotherapies, support early-stage UConn-related companies, and promote SaaS solutions for coupon clearing in retailers.

Overall, Kevin Crowley has shown strong expertise in investments and board roles, with a focus on supporting innovative and transformative technologies in various industries.

Kevin Crowley completed their high school education at Suffield High School. Kevin then went on to attend Quinnipiac University from 1993 to 1997, where they obtained a Bachelor of Science degree in Management. Later, they pursued further education at Quinnipiac University from 1997 to 2000 and earned a Master of Business Administration (MBA) specializing in Strategic Planning and Organizational Theory.